Translate AMICOR contents if you like

Thursday, February 14, 2019

Prime Prevention Aspirin?

January 23, 2019
A new meta-analysis of trials evaluating aspirin for primary prevention of cardiovascular disease has found no overall benefit, with aspirin use associated with a lower risk of cardiovascular events but an increased risk of major bleeding, and no effect of aspirin on cancer risk.
However, there still appears to be some disagreement on how to apply these findings. 

No comments: